The number of people who have complained of serious bleeding issues after taking the anticoagulant Pradaxa (dabigatran) runs in thousands. Hundreds of people have lost their lives.
This anticoagulant has been linked to internal bleeding, gastrointestinal bleeding, brain hemorrhage, bleeding kidneys, and death. The drug, manufactured by Boehringer Ingelheim Pharmaceuticals, was approved by the U.S. Food and Drug Administration (FDA) in October 2010. Since then, doctors have prescribed Pradaxa to millions of patients.
In 2011, Pradaxa use led to the deaths of more than 540 patients. A multidistrict litigation (MDL) was filed in the U.S. District Court for the Southern District of Illinois. In 2014, Boehringer Ingelheim agreed to pay more than $650 million to settle 4,000 lawsuits.
Lawsuits filed over injuries and deaths claimed that the company aggressively marketed the drug and did not inform about the potential risks and chances of developing life-threatening bleeds.
People who filed Pradaxa lawsuits did so to recover hospital expenses, loss of income, and also cost of funerals. Many litigants filed cases only because they did not want others to go through the trauma they went through. Boehringer Ingelheim made Pradaxa available without providing an antidote for complications that may occur. This is in stark contrast to warfarin. Doctors can reverse internal hemorrhaging caused by warfarin. Moreover, this drug was presented as being superior to warfarin because it ostensibly did not require frequent blood monitoring. In hindsight, it appears that blood monitoring would have prevented many of the injuries and fatalities that are associated with Pradaxa.
All blood thinners come with the risk of gastrointestinal bleeding; however, the risk is higher with Pradaxa and this was not adequately reflected on its warning label. In fact, within the first three months of its availability, the drug was associated with no less than 307 cases of internal bleeding. In the first year of its use by the general public, Pradaxa was associated with more than 260 fatalities.
Critics of the drug manufacturer have alleged that the clinical trials for Pradaxa were not held in the right manner. There is a growing demand for Pradaxa recall to prevent further injuries and deaths. If you have suffered problems because of Pradaxa, you should check your eligibility to pursue a lawsuit against the manufacturer.
The Law Offices of Alex R. Hernandez Jr. can help those who have suffered because of Pradaxa complications. Our team of lawyers has the experience in litigating claims and we can help you get the justice you deserve for your injuries.
Call Alex R. Hernandez Jr. Today 1-888-HDZ-LAW-8.
921 N. Chaparral Suite 100 Corpus Christi, Texas 78401Phone: 361-792-3811